{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T07:12:36Z","timestamp":1794467556938,"version":"4.9.1"},"reference-count":17,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1497,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1111\/j.1751-7176.2011.00513.x","type":"journal-article","created":{"date-parts":[[2011,7,27]],"date-time":"2011-07-27T17:52:15Z","timestamp":1311789135000},"page":"687-689","source":"Crossref","is-referenced-by-count":277,"title":["Calcium Channel Blockers"],"prefix":"10.1111","volume":"13","author":[{"given":"William J.","family":"Elliott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Venkata S.","family":"Ram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,7,27]]},"reference":[{"key":"10.1111\/j.1751-7176.2011.00513.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1056\/NEJM199911043411907","article-title":"Calcium-antagonist drugs","volume":"341","author":"Abernethy","year":"1999","journal-title":"N Engl J Med."},{"key":"10.1111\/j.1751-7176.2011.00513.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0895-7061(94)00247-9","article-title":"Calcium channel blockers: is it time to split the lump?","volume":"8","author":"Materson","year":"1995","journal-title":"Am J Hypertens."},{"key":"10.1111\/j.1751-7176.2011.00513.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure. National High Blood Pressure Education Program Coordinating Committee","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension."},{"key":"10.1111\/j.1751-7176.2011.00513.x-BIB4|cit4","article-title":"Hypertension: management of hypertension in adults in primary care (partial update of NICE Clinical Guideline 18)","author":"Littlejohns","journal-title":"National Institute for Health and Clinical Excellence"},{"key":"10.1111\/j.1751-7176.2011.00513.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0002-9149(00)01413-2","article-title":"Meta-analysis of efficacy and safety of second-generation dihydropyridine calcium channel blockers in heart failure","volume":"87","author":"Cleophas","year":"2001","journal-title":"Am J Cardiol."},{"key":"10.1111\/j.1751-7176.2011.00513.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"b1665","DOI":"10.1136\/bmj.b1665","article-title":"Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies","volume":"338","author":"Law","year":"2009","journal-title":"BMJ."},{"key":"10.1111\/j.1751-7176.2011.00513.x-BIB7|cit7","article-title":"Antihypertensive treatment and development of heart failure in hypertension: a Bayesian network meta-analysis of studies in patients with hypertension and high cardiovascular risk","volume":"170","author":"Sciarretta","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1751-7176.2011.00513.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1001\/jama.285.21.2719","article-title":"Effect of ramipril vs. amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial","volume":"285","author":"Agodoa","year":"2001","journal-title":"JAMA"},{"key":"10.1111\/j.1751-7176.2011.00513.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to Type 2 diabetes. Collaborative Study Group","volume":"345","author":"Lewis","year":"2001","journal-title":"N Engl J Med."},{"key":"10.1111\/j.1751-7176.2011.00513.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1001\/jama.289.16.2073","article-title":"Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular Endpoints (CONVINCE) Trial","volume":"289","author":"Black","year":"2003","journal-title":"JAMA"},{"key":"10.1111\/j.1751-7176.2011.00513.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1001\/jama.290.21.2805","article-title":"A calcium antagonist vs. a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease: The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial. The INVEST Investigators","volume":"290","author":"Pepine","year":"2003","journal-title":"JAMA."},{"key":"10.1111\/j.1751-7176.2011.00513.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0140-6736(00)02526-5","article-title":"Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: The Nordic Diltiazem (NORDIL) Study","volume":"356","author":"Hansson","year":"2000","journal-title":"Lancet"},{"key":"10.1111\/j.1751-7176.2011.00513.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0140-6736(00)02527-7","article-title":"Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT)","volume":"356","author":"Brown","year":"2000","journal-title":"Lancet"},{"key":"10.1111\/j.1751-7176.2011.00513.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":"Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial","volume":"351","author":"Hansson","year":"1998","journal-title":"Lancet"},{"key":"10.1111\/j.1751-7176.2011.00513.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1097\/01.hjh.0000194120.42722.ac","article-title":"The Felodipine Event Reduction (FEVER) study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients","volume":"23","author":"Liu","year":"2005","journal-title":"J Hypertens"},{"key":"10.1111\/j.1751-7176.2011.00513.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(05)67185-1","article-title":"Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial","volume":"366","author":"Dahl\u00f6f","year":"2005","journal-title":"Lancet"},{"key":"10.1111\/j.1751-7176.2011.00513.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1056\/NEJMoa0806182","article-title":"Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients","volume":"359","author":"Jamerson","year":"2008","journal-title":"N Engl J Med"}],"container-title":["The Journal of Clinical Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1751-7176.2011.00513.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T08:11:23Z","timestamp":1625559083000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1751-7176.2011.00513.x"}},"subtitle":["Calcium Channel Blockers"],"short-title":[],"issued":{"date-parts":[[2011,7,27]]},"references-count":17,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,9]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1751-7176.2011.00513.x","relation":{},"ISSN":["1524-6175"],"issn-type":[{"value":"1524-6175","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7,27]]}}}